Agios Pharma (AGIO) Tops Q4 EPS by 12c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.60), $0.12 better than the analyst estimate of ($1.72). Revenue for the quarter came in at $35.4 million versus the consensus estimate of $33.72 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Hermès can regain momentum despite China weakness, Jefferies says